New Zealand markets close in 3 hours 33 minutes

MRNA Jan 2024 155.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.0500-0.1000 (-8.70%)
As of 09:59AM EDT. Market open.
Full screen
Previous close1.1500
Open1.0500
Bid1.0600
Ask1.1100
Strike155.00
Expiry date2024-01-19
Day's range1.0500 - 1.0500
Contract rangeN/A
Volume50
Open interestN/A
  • Bloomberg

    Scientists Behind Pfizer and Moderna mRNA Vaccines Win Nobel

    (Bloomberg) -- Two scientists won the Nobel Prize in medicine for research that laid the groundwork for some of the best-selling medicines of all time: the messenger-RNA vaccines against Covid-19.Most Read from BloombergWhy a US Recession Is Still Likely — and Coming SoonAirbnb Is Fundamentally Broken, Its CEO Says. He Plans to Fix It.Severe Crash Is Coming for US Office Properties, Investors SayBond Selloff Batters Stocks, But Spares Big Tech: Markets WrapJPMorgan’s Dimon Predicts 3.5-Day Work

  • Motley Fool

    3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

    These companies are helping change medicine; they could make boatloads of money along the way.

  • Motley Fool

    Moderna's Shares Could Take Off if These 2 Things Happen

    Moderna (NASDAQ: MRNA) used to be a stock market star, climbing 1,700% from the start of 2020 through July of 2021. Investors liked that, and it clearly showed in the stock performance. After all, the vaccine is Moderna's only product right now, and demand for it has declined.